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Abstract: 
As part of the pksX gene cluster of Bacillus subtilis strain 168, pksS has been preliminarily annotated as a 
cytochrome P450 homolog that hydroxylates the polyketide product of this cluster, which was recently shown 
to be involved in the biosynthesis of bacillaene and dihydrobacillaene. Here we report that there is a frame-shift 
error in the reported sequence for pksS, and that we have successfully cloned, overexpressed, and purified the 
protein encoded by the corrected sequence. By utilizing electronic absorption spectrophotometry, we have 
observed that the ferrous CO complex of PksS absorbs maximally near 450 nm, which confirms the annotation 
that this protein is a cytochrome P450. We have also established a cell-free system derived from crude cytosolic 
B. subtilis protein extracts which provides reductase activity essential to sustaining the putative catalytic cycle 
of PksS. Using LC–MS analysis we have collected data which suggests that the substrate for PksS is 
dihydrobacillaene. 
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Article: 
 
Genes from the polyketide biosynthetic pksX cluster (Fig. 1) of Bacillus subtilis strain 168 were first reported in 
1993 [1,2], and preparations of the antibiotic polyketide bacillaene (Fig. 1) were first reported in 1994 [3]. 
However, the linkage between pksX and bacillaene biosynthesis was not confirmed until 2006 [4], and the 
structure of bacillaene and its reduced derivative dihydrobacillaene had not been solved until recently in 2007 
[5]. This information has been elusive because bacillaene and dihydrobacillaene are unstable and difficult to 
isolate [5], and reports in the literature have indicated that these compounds are part of a complex mixture of 
several chromatographically distinct isomers and derivatives [3,5,6]. Indeed, the structures of these sensitive 
compounds were out of reach until workers utilized overlay differential 2D NMR techniques [7] on partially 
purified mixtures of material obtained from pksX
+
 strains and pksX
-
 mutants [5]. 
 
In order to explore the poorly understood role of polyketides in the secondary metabolism of B. subtilis, it is 
important to understand, at the biochemical level, the individual functions of each protein product of the pksX 
cluster. The arrangement of domains within the ―Acyl Transferase (AT)-less‖ [8] polyketide synthases 
PksJLMNR, (with the requisite trans-AT activities likely being furnished by PksDE) and knowledge of the steps 
catalyzed by the β-branch synthases PksCFGHI, and AcpK [9,10], has led to the suggestion that the first 
polyketide product of the pksX cluster is bacillaene [5]. This assignment has not been proven biochemically, and 
a de novo interpretation of the sequence of modules and domains within these synthases does not directly 
explain the source of dihydrobacillaene, nor indicate whether this and other potential derivatives of bacillaene 
are the products of (1) module or domain skipping in the modular synthases, (2) post-polyketide synthase 
enzymes, or (3) nonenzymatic degradation pathways. Each of these questions represents a gap in our knowledge 
of polyketide metabolism in B. subtilis. 
 
For the possibility of post-polyketide synthase manipulation, we can first consider the remaining genes from the 
pksX cluster. These are pksAB, which appear to encode a transcriptional regulator and zinc-dependent 
hydrolase, respectively; and pksS, which has been assigned by significant sequence similarity as a cytochrome 
P450 homolog that hydroxylates the polyketide product (i.e., bacillaene or dihydrobacillaene) of the pksX 
cluster [11–13]. As such, pksS is expected to be a useful tool for developing a complete picture of post-
polyketide synthase bacillaene metabolism. Here we describe the necessary first steps towards uncovering the 
function of pksS. 
 
MATERIALS AND METHODS 
 
Bacterial strains, culture conditions, and DNA. 
Bacillus subtilis strain 168 (trpC2) (BS168) was obtained from the Bacillus Genetic Stock Center at Ohio State 
University (BGSC code = 1A1). B. subtilis ATCC strain 39374 was obtained from the American Type Culture 
Collection (Manassas, VA). Escherichia coli M15[pREP4] and the pQE60 plasmid were obtained from Qiagen, 
Inc. E. coli strains were grown in standard Luria–Bertani (LB) medium, and BS168 was grown in well-aerated 
LB medium. ATCC strain 39374 was grown in well-aerated Landy medium for the production of bacillaenes 
[14]. Genomic DNA from BS168 was purified using a Wizard Genomic DNA Purification Kit from Promega, 
according to the manufacturer’s instructions. All plasmid DNA was purified using the Qiaprep Spin Miniprep 
Kit (Qiagen, Inc.). 
 
Cloning and overexpression of pksS. 
Standard methods were used for restriction endonuclease digestions, ligation, and chemical bacterial 
transformation [15]. PCR amplification of complete pksS from BS168 genomic DNA was accomplished using 
Phusion polymerase (New England Biolabs) and the primers 5'-CG AGG ACC ATG GAA ATG GAA AAA 
TTG-3' and 5'-GGG GCG TTT TGA AGA TCT TTT TGA AAG TGA AAC AGG-3'. The PCR product was 
purified with a Qiagen PCR Cleanup Kit, cut with NcoI and BglH, and ligated into the NcoI and BglH sites of 
pQE60 with T4 DNA ligase to yield pksS-pQE60. This vector was constructed such that the native stop codon 
of pksS was replaced in frame by a plasmid-encoded C-terminal His6-Tag sequence. All plasmid-clones were 
verified by dye-terminated sequencing performed by SeqWright, Inc. (Houston, TX). 
 
One pksS-pQE60/M15[pREP4] transformant was grown overnight in 5 mL of LB supplemented with ampicillin 
(50 µg/mL) and kanamycin (30 µg/mL). A portion of the starter culture (2 mL) was then added to 1 L of LB 
containing 1% glucose, ampicillin (50 µg/mL), kanamycin (30 µg/ mL), and was shaken at 37°C until an OD595 
of 0.5–0.6 was reached. IPTG was added (0.6 mM final concentration) and the culture was then allowed to 
shake for 3 h at 37 °C. The cells were harvested by centrifugation (7500g for 30 min) and the pellet was stored 
at —80 °C until purification. 
 
Purification of the PksS protein. 
All steps in this section were conducted at 4 °C, unless otherwise noted. The pelleted cells obtained from 1 L of 
overexpression culture were resuspended in 20 mL binding buffer (5 mM imidazole, 500 mM NaCl, 20 mM 
Tris–HCl, pH 7.9) and lysed by sonication on ice for 3 min. The lysate was clarified by centrifugation (11,500g 
for 30 min), followed by syringe-filtration through a 0.45 µm membrane. The clarified filtrate was applied to a 
nickel–nitrilotriacetic acid (Ni–NTA) affinity chromatography column containing 2 mL of packed column bed. 
After loading the entire crude extract, 20 mL of binding buffer was passed through the column. Twelve 
milliliters of wash buffer (60 mM imidazole, 500 mM NaCl, 20 mM Tris–HCl, pH 7.9) was added to the 
column, followed by 12 mL of elution buffer (1 M imidazole, 500 mM NaCl, 20 mM Tris–HCl, pH 7.9), which 
eluted PksS from the column. To exchange the buffer, the protein was quickly passed through a Sephadex G25 
gel filtration column, using 50 mM potassium phosphate buffer (pH 8.0) as eluent. Sterile glycerol was added to 
give a final concentration of 10%, and the protein was stored at —80 °C. The purity and size of the PksS protein 
were estimated by 12% Tris–glycine sodium dodecyl sulfate–polyacrylamide gel electrophoresis (SDS–PAGE) 
according to the method of Laemmli [16]. 
 
Spectrophotometric analysis of PksS. 
A 2 ml sample of purified PksS protein in 50 mM potassium phosphate, pH 8.0 was treated with approximately 
5 mg of sodium dithionite. The sample was divided for placement in the sample and reference cells of a Varian 
Cary 100 Bio UV–visible spectrophotometer. The visible spectrum was recorded between 400–500 nm, after 
which the 1 mL sample cell was sparged with carbon monoxide for approximately 1 min. With a reduced PksS 
sample (having no CO) remaining in the reference cell, the spectrum of the CO-complexed reduced PksS was 
recorded between 400 and 500 nm. 
 
Preparation of cell-free protein extract as source of PksS reductase. 
An overnight starter culture (5 mL) of BS168 was used to inoculate 500 mL of LB media, and was shaken at 
37°C for 2 days. The culture was pelleted by centrifugation (8500g for 30 min), resuspended in 10 mL of 50 
mM phosphate buffer, pH 8.0, and lysed on ice with lysozyme and sonication. The lysate was cleared by 
centrifugation (11,500g for 30 min), the supernatant was filtered through a 0.45 µm membrane, and the filtrate 
was used without further modification in the PksS reductase assay given below. 
 
Assay for PksS reductase activity. 
First, a PksS solution was placed in a quartz cuvette, and sealed with a rubber septum. The system was placed 
under a controlled atmosphere in a Schlenck apparatus via needle. To remove all oxygen gas (which would 
interfere with the reduction of PksS) the solution was subjected to sparging by argon followed by evacuation 
under high-vacuum. The sparging/evacuation process was repeated two more times. After the deoxygenation of 
the sample, CO-difference spectra were taken as above, except sodium dithionite was not used, CO was bubbled 
into the sealed cuvette via needle and proper venting, and NADH and reductase solutions were successively 
added by syringe. 
 
Analysis of ATCC strain 39374 small molecule extracts treated with PksS system. 
An overnight starter culture of ATCC 39374 was grown in LB media, of which 100 µL was used to inoculate 50 
mL of Landy medium. This culture was shaken at 37 °C for 72 h at 220 rpm. Samples of the raw culture (0.5 
mL), including the medium, were extracted with 1 mL of HPLC-grade methanol, vortexed vigorously, and 
centrifuged at top speed for 2 min. The supernatant was separated from the pellet, and the methanol was 
removed by centrifuged evacuation in a Speedvac apparatus. The resultant residue was redissolved in 0.5 mL of 
50 mM potassium phosphate buffer, pH 8.0. Reactions of a total volume of 600 µL contained 4 µM PksS, 80 
µM of either NADH/NADPH, 60 µL of BS168 crude protein extract as a source of PksS reductase (as above 
from a 10 mL crude extract obtained from 500 mL culture), and the 0.5 mL of bacillaene methanolic extract 
(from above). Each reaction was incubated at room temperature for 1 h and then filtered using a 0.45 µm 
membrane. The samples were then analyzed by LC–MS on a LCQ-Advantage ion trap mass spectrometer in 
positive mode, which was coupled to a HP1100 HPLC using a 5 mM Prevail C-18 column (Alltech). The 
gradient elution profile was as follows: Begin at 95:5 1% acetic acid:acetonitrile, with the acetonitrile increasing 
to 95% over a 45 min linear gradient at 0.2 mL/min flow rate. 
 
RESULTS AND DISCUSSION 
 
Using the published sequence data for strain 168 pksS as a guide [11], we conducted several trials of PCR 
cloning and sequencing, which revealed that pksS in actuality lacks guanosine 1111 (with the first nucleotide of 
the pksS start codon being numbered as 1). Removal of this false G from the reported sequence shifts the 
original stop codon (which started at 1129 bp) out of frame, and the next available in-frame stop codon 
indicated that the amino-acid coding portion of the pksS open reading frame is 1221 bp instead of the previously 
assigned 1128 bp. The PksS protein should thus have 408 amino acids instead of the previously predicted 376 
amino acids. The expected pksS protein product can be compared to the pksS ortholog baeS (Gen- Bank 
Accession No. CAG23962) from B. amyloliquefaciens FZB42 [4]. The bae cluster of B. amyloliquefaciens, 
which also encodes the biosynthesis of the bacillaenes, is a nearly exact replica of the pksX cluster of B. subtilis. 
The baeS gene is located on the complementary strand at the end of the bae cluster, in the same orientation with 
respect to the overall cluster, as with pksS in pksX shown in Fig. 1. A pairwise global alignment of the original 
pksS protein sequence and the baeS protein sequence using the BLOSUM62 similarity matrix [17] resulted in an 
alignment score of 1400 with 68% sequence identity and 78% similarity. The corresponding alignment of the 
corrected pksS protein sequence with baeS resulted in a higher alignment score of 1577 with 73% identity and 
84% similarity, all indicating a better alignment. The newly assigned stretch of 
~30 amino acids at the C-terminus of PksS has a clear well-aligned counterpart at the C-terminus of the 
independently sequenced baeS protein. These factors are suggestive that this additional stretch of C-terminal 
sequence should be important for the structure and function of PksS. The corrected sequences (DNA and amino 
acid) are available (GenBank Accession No. EF546698). 
 
We employed PCR to clone the corrected pksS sequence into the pQE60 overexpression vector. Sequencing of 
this clone verified that the insert had the expected sequence, minus the aberrant G. This plasmid was 
overexpressed in E. coli strain M15[pREP4], and the cells were lysed by sonication. Ni–NTA chromatography 
of the cleared lysate resulted in an intensely orange-colored protein eluent, which was shown by SDS–PAGE 
(see Fig. 2) to have a >95% pure constituent with a denatured molecular mass of approximately 47 kDa, which 
is consistent with the calculated mass of the corrected amino acid sequence of PksS. On average, a yield of 0.12 
µmol (5.6 mg) of P450 was obtained per liter of culture. 
 
Having successfully isolated the PksS protein, we turned to characterizing this protein with respect to its 
expected identity as a cytochrome P450 homolog. Diluted samples of the purified protein were treated with 
sodium dithionite, and exposed to carbon monoxide. Visible spectra were immediately taken, and an intense 
Soret peak at 448 nm was observed (Fig. 3), demonstrating that PksS indeed satisfies the spectral definition of a 
cytochrome P450 protein [18]. 
 
There are currently two obstacles to a full characterization of PksS. The first is that we do not know the identity 
of the reductase which maintains the activity of PksS. The two major classes of reductases are the Class I 
(ferredoxin/ ferredoxin reductase) and the Class II (a membrane-bound flavoprotein) [19]. Unfortunately, there 
are no homologs of Class I or Class II reductase systems proximal to pksS, and there are a large abundance of 
genes in the genome which show similarity to a wide variety of electron transport motifs, including those 
common to P450 reductases. We 
 
 
 
 
have shown that crude protein extracts from BS168 are able to induce formation of the PksS-dependent 448 nm 
peak, when NADH and CO are present, and only if oxygen was thoroughly removed from the sample. Research 
is currently underway to isolate and characterize the genetic source(s) for this native PksS reductase system. 
 
The second challenge to studying this cytochrome P450 is that the identities of its substrate(s) and product(s) 
are unknown. The annotation from the genome project has merely assigned pksS as a putative hydroxylase of 
the product of the pksX cluster. Several compounds and isomers dependent on the pksX cluster have been noted, 
and only bacillaene and dihydrobacillaene have been structurally characterized. It is not clear which of these 
two (if any) should be assigned as the genetically encoded product of the polyketide synthases, though domain 
analysis of these synthases led to the proposal that bacillaene is the immediate product. Whereas polyketide-
modifying cytochrome P450s are typically hydroxylases [20,21] or epoxidases [22], no epoxy-bacillaene is 
known; and all of the hydroxyl groups on bacillaene or dihydrobacillaene can reasonably be explained by the 
domain content of the PksJLMNR synthases. 
 
In order to determine the substrate for PksS, we incubated PksS/reductase with crude methanolic extracts of 
metabolites from the B. subtilis strain ATCC 39374, a wild-type producer of the bacillaene and difficidin 
polyketides [23–25]. We turned to this strain because we have found that it consistently yielded known 
polyketide products in a reproducible manner. After removal of the methanol, the ATCC 39374 extracts were 
treated with purified PksS, crude reductase, NADH, NADPH, and the resulting mixtures were analyzed by LC–
MS (Fig. 4). In all samples, with or without any of the added P450 components, there is one major peak (not 
shown in Fig. 4) with a mass of 599 m/z, which is consistent either with a hydrated bacillaene or hydroxylated 
dihydrobacillaene [bacillaene + 18 + H
+
]. There were two other less-intense peaks, the first with a mass of 581 
m/z (consistent with [bacillaene + H
+
]) and the second had a mass of 583 m/z (consistent with 
[dihydrobacillaene + H
+
]). When the same extracts were treated with the full complement of PksS and cofactors, 
the 583 m/z peak corresponding to dihydrobacillaene was eliminated, with no apparent change in the putative 
hydrated bacillaene (m/z = 599) and unhydrated bacillaene (m/z = 581) peaks. These results suggest that 
dihydrobacillaene, and not bacillaene, is the substrate for PksS, though the complexity of the mixture has not 
allowed us to unambiguously assign the product. We propose two possibilities for this product, that are each 
consistent with available data. 
 
The first proposal is that bacillaene exits the polyketide synthase as recently postulated, and an unknown 
reductase converts it to dihydrobacillaene. PksS would then follow to form a hydrated bacillaene (equivalent to 
hydroxylated dihydrobacillaene), which has never been characterized. Our second suggestion is that 
dihydrobacillaene exits the polyketide synthase, and PksS hydroxylates it at either C14' or C15', which is 
ultimately eliminated to form bacillaene. Since the function of the pksJLMNR synthases has not been 
biochemically confirmed, we expect that PksS will be a useful tool for marking structural features which are not 
originated by the polyketide synthase repertoire. Our efforts in characterizing the product of the PksS reaction 
will be reported in due course. 
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